标普和纳斯达克内在价值 联系我们

Prelude Therapeutics Incorporated PRLD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.25
+13.2%

Prelude Therapeutics Incorporated (PRLD) has 18 已知的内部人和机构持有人记录. 最大持有人为 ORBIMED ADVISORS LLC 持有 10,119,756 股. 其他重要持有人包括 Vaddi Krishna 和 Lim Bryant David.

过去12个月,内部人进行了 16 笔交易,涉及 PRLD 股票 — 11 笔买入 (价值为 $4.06M) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出,可能表明对公司前景有信心.

PRLD 內部人持股

最大持股人
ORBIMED ADVISORS LLC
10,119,756 股
买入(12个月)
11
$4.06M 价值
卖出(12个月)
0
$0.00 价值
12个月交易活动
买入 69%
卖出 0%
主要內部人持股
# 姓名 职位 持股数量 最近申报日期 相对规模
1 Orbimed Advisors Llc 10 Percent Owner 10,119,756 2023-05-24
100%
2 Vaddi Krishna CEO 837,000 2026-02-05
8%
3 Lim Bryant David CLO, CFO, Corp Sec. 275,000 2026-02-05
3%
4 Scherle Peggy Chief Scientific Officer 230,000 2026-02-05
2%
5 Combs Andrew Chief Chemistry Officer 230,000 2026-02-05
2%
6 Chardonnet Laurent Chief Financial Officer 150,000 2024-03-04
1%
7 Sandor Victor Director 121,285 2025-11-07
1%
8 Piper Brian Chief Financial Officer 115,650 2021-07-22
1%
9 Mauro David J Chief Medical Officer 95,000 2021-07-22
1%
10 Morosini Deborah EVP, Chief of Clinical Affairs 90,000 2022-02-17
1%
11 Baker Bros. Advisors Lp 10 Percent Owner 76,000 2025-06-13
1%
12 Dier Mardi Director 38,000 2025-06-13
0%
13 Bonita David P 10 Percent Owner 38,000 2025-06-13
0%
14 Babler Martin Director 38,000 2025-06-13
0%
15 Friedman Paul A Director 38,000 2025-06-13
0%
16 Baker Brothers Life Sciences Lp Director 34,300 2022-06-22
0%
17 Huang Jane President, CMO 18,750 2025-10-07
0%
18 Pierce Christopher EVP and Chief of Business Oper 3,750 2021-09-07
0%
近期交易 (过去12个月)
日期 姓名 职位 类型 股数 股价 总价值
2026-03-05 Brusky Sean P. Chief Business Officer 未知 275,000 - -
2026-02-04 Combs Andrew Chief Chemistry Officer 限制性股票授予 (RSU) 230,000 $2.30 $529K
2026-02-04 Vaddi Krishna CEO 限制性股票授予 (RSU) 837,000 $2.30 $1.93M
2026-02-04 Scherle Peggy Chief Scientific Officer 限制性股票授予 (RSU) 230,000 $2.30 $529K
2026-02-04 Lim Bryant David CLO, CFO, Corp Sec. 限制性股票授予 (RSU) 275,000 $2.30 $632.5K
2025-11-05 Sandor Victor Director 限制性股票授予 (RSU) 121,285 $1.39 $168.59K
2025-10-17 Dorton Katina Officer 未知 - - -
2025-10-04 Huang Jane President, CMO 期权行权(卖出) 9,375 - -
2025-07-04 Huang Jane President, CMO 期权行权(卖出) 9,375 - -
2025-06-12 Scherer Paul C Officer 未知 - - -
2025-06-12 Sandor Victor Director 限制性股票授予 (RSU) 38,000 $1.04 $39.52K
2025-06-12 Dier Mardi Director 限制性股票授予 (RSU) 38,000 $1.04 $39.52K
2025-06-12 Bonita David P 10 Percent Owner 限制性股票授予 (RSU) 38,000 $1.04 $39.52K
2025-06-12 Babler Martin Director 限制性股票授予 (RSU) 38,000 $1.04 $39.52K
2025-06-12 Baker Bros. Advisors Lp 10 Percent Owner 限制性股票授予 (RSU) 76,000 $1.04 $79.04K
2025-06-12 Friedman Paul A Director 限制性股票授予 (RSU) 38,000 $1.04 $39.52K
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言